ATAI Investor Presentation Deck
January 2024, 34 slides
  1. ATAI
  2. Related Decks
  3. Investor Presentation Decks
company overview healing mental health disorders so that everyone everywhere can live a more life | ATAI
disclaimer | ATAI
mental health disorders are one of the global health burdens in in every people or million people around the world were living with a mental disorder objective is to achieve clinically meaningful and sustained behavioral change in mental health patients by developing rapid acting and durable therapeutics eight clinical stage drug development programs and strategic investments each with a robust package of prior clinical evidence validated operating model and ability to capture value of compass pathways in and licensing deal between and subsidiary perception in cash marketable securities and committed term loan funding are expected to provide runway into life sciences healing so that everyone everywhere can live more life | ATAI
our strategy will be delivered through a robust portfolio of and non drug development programs and strategic investments | ATAI
life sciences operational focus program guidance | ATAI
for alcohol use disorder | ATAI
results from completed phase sad study showed had a favorable safety profile and was well tolerated whilst demonstrating dose proportionate profile | ATAI
core study weeks phase a is an open label in patients | ATAI
phase is a randomized double blind single dose study in moderate to severe patients | ATAI
for | ATAI
product overview for depression | ATAI
clinical evidence efficacy in randomized control trial of in | ATAI
program status phase expected in clinical trial design results | ATAI
for and anorexia | ATAI
summary phase trial showed a rapid sustained reduction in depressive symptoms | ATAI
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
for | ATAI
reduced variability shorter half life shorter duration of effect anticipated to be hours potential benefits active moiety in an optimized delivery and treatment model | ATAI
randomized phase dose study in healthy volunteers followed by phase a open label study in | ATAI
for substance use disorder | ATAI
product overview for use disorder | ATAI
clinical evidence efficacy of in open label safety and efficacy study | ATAI
demonstrated safety level and plasma concentrations of in line with previous trials potential therapeutic plasma levels no serious adverse events reported asymptomatic prolongation phase study trial design results summary | ATAI
summary could potentially become a paradigm shifting therapy for use disorder has the potential to the first best in class treatment minimizing risk of relapse | ATAI
for at impairment | ATAI
product overview for cognitive impairment | ATAI
clinical evidence efficacy on cognitive in a phase study | ATAI
clinical evidence efficacy signals reproduced in phase a study in | ATAI
trial status first patient dosed in topline data anticipated mid clinical design phase study | ATAI
for anxiety disorders | ATAI
product overview for anxiety disorders | ATAI
demonstrated a rapid and dose dependent effect along with a safety profile target engagement demonstrated safe well tolerated sedation comparable to placebo phase study trial design results summary | ATAI
beta power increase is in line with pharmacodynamic efficacy of exogenous phase study evidence target engagement | ATAI
| ATAI
See More
ATAI
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Mental health
Recent decks by ATAI
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Investor Presentation
March 2023
See all presentations by ATAI (13 decks)
Related decks
MindMed
Investor Presentation
April 2021
Talkspace
Results
February 2023
Recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Investor Presentation
March 2023
MindMed
Investor Presentation
April 2021
Talkspace
Results
February 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io